CYP3A4 and metabolic dysfunction-associated steatohepatitis: Moreover, the proinflammatory and proinflammatory/obese medium impaired CYP3A4 activity in hepatocytes, a result that aligned well with the CYP3A4 activity found in MASH patients and in in vitro MASH models.